NervGen Pharma Corp.

NGEN

$1.74

▼ -2.2% Today

as of Jul 22, 09:07 ET

Last 30 days -7.29% Jun 12 → Jul 21

Open

$2.04

High

$2.05

Low

$1.85

Volume

$1M

Avg Vol

$243,359

Mkt Cap

$171M

P/E (TTM)

—

Beta

—

52w High

$6.30

52w Low

$1.85

Div Yield

—

Shares Out

—

Recent Press Releases & News last 60 days · 2 items

Jun 11 · 10:26 MT Newswires

TD Cowen Initiates NervGen Pharma at Buy

May 26 · 11:15 PR GlobeNewswire

NervGen Announces Positive Independent, Blinded Biomechanical Gait Analyses Demonstrating Genuine Neural Recovery with NVG-291 in Phase 1b/2a CONNECT SCI Study

Overview

52-week range

$1.85

$6.30

0% of range

Avg surprise (last 1)

-28.6%

Avg reaction (last 1)

-3.9%

0% positive

Latest IV / EM

507%

EM ±118.0% · $3 · Aug 21

Earnings trends

EPS — actual vs estimate Actual Estimate

Earnings history

Date	Period	Actual EPS	Est	Surprise	YoY %Δ	Day react	Source
Fri May 15, 2026	Mar/2026	$-0.09	$-0.07	-28.6%	—	-3.9%	earnings

Implied volatility — last 90 days

View on Nasdaq ↗